文献速递妇产影像神经儿科影像USMR

开放性脊柱裂胎儿透明隔腔穿孔与1岁前需脑积水治疗的关系

Perforation of cavum septi pellucidi in open spina bifida and need for hydrocephalus treatment by 1 year of age.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

回顾性队列研究纳入110例2014至2021年在单中心接受腹腔镜辅助胎儿镜开放性神经管缺陷修复的连续病例,术前及术后6周行超声和MRI评估透明隔腔完整性。术前超声显示透明隔腔穿孔者术后后脑疝逆转率更低(65.0% vs 88.6%,P=0.01),1岁内需脑积水治疗比例更高(89.5% vs 22.7%,P<0.01);MRI未见后脑疝逆转是需脑积水治疗的最强预测因子(OR 36.20,95%CI 5.96-219.12)。

要点

  • 胎儿开放性神经管缺陷修复前超声发现透明隔腔穿孔提示1岁内需脑积水治疗风险高(89.5% vs 22.7%)。
  • MRI未见后脑疝逆转是需脑积水治疗的最强预测因子(OR 36.20,95%CI 5.96-219.12)。
  • 术前超声透明隔腔穿孔者术后后脑疝逆转率更低(65.0% vs 88.6%,P=0.01)。

核心结论

  • 胎儿开放性神经管缺陷修复前及术后6周超声或MRI检出透明隔腔穿孔,可识别1岁内需脑积水治疗的高风险病例,有助于对考虑胎儿手术的家庭进行咨询并设定对出生后结局的合理预期。

研究设计与样本

  • 回顾性队列研究,纳入2014至2021年单中心连续接受腹腔镜辅助胎儿镜开放性神经管缺陷修复的患者110例,手术 eligibility 基于MOMS标准但允许母亲孕前BMI高达40 kg/m2,于转诊时及术后6周行胎儿脑超声和MRI,回顾性判读存储的超声和MRI图像评估透明隔腔完整性,并查阅病历确定1岁内是否需要脑积水治疗。

关键影像表现/征象

  • 术前超声和MRI分别有20.6%和22.6%病例检出透明隔腔穿孔,术后超声和MRI分别有26.6%和24.2%检出。
  • 从转诊至术后心室尺寸增大(中位数11.00 mm〔范围5.89-21.45〕 vs 16.00 mm〔范围7.00-43.5〕,P<0.01),严重脑室扩大(心室宽度≥15 mm)比例升高(12.7% vs 57.8%,P<0.01)。
  • 术前超声透明隔腔穿孔组较完整组心室更大(均值14.32±3.45 mm vs 10.37±2.37 mm,P<0.01),严重脑室扩大比例更高(40.9% vs 5.9%,P<0.01)。
  • 术后6周同样趋势:透明隔腔穿孔组心室尺寸中位数21.0 mm〔范围13.0-43.5〕 vs 14.3 mm〔范围7.0-29.0〕(P<0.01),严重脑室扩大95.0% vs 46.8%(P<0.01)。
  • 转诊时透明隔腔穿孔者术后后脑疝逆转率更低(65.0% vs 88.6%,P=0.01),需脑积水治疗比例更高(89.5% vs 22.7%,P<0.01)。

诊断标准与关键数值

  • 术前超声完整评估透明隔腔的107例中,22例穿孔、85例完整,穿孔组严重脑室扩大(心室宽度≥15 mm)比例为40.9% vs 完整组5.9%(P<0.01)。
  • 预测1岁内需脑积水治疗:MRI未见后脑疝逆转OR 36.20(95%CI 5.96-219.12,P<0.01),术前超声透明隔腔穿孔OR 23.40(95%CI 5.42-100.98,P<0.01),术后6周超声透明隔腔穿孔OR 19.48(95%CI 5.68-66.68,P<0.01)。

临床应用与阅片要点

  • 胎儿开放性神经管缺陷修复前及术后6周应评估透明隔腔完整性,穿孔提示1岁内需脑积水治疗风险高。
  • MRI评估后脑疝是否逆转对预测需脑积水治疗具有重要价值(OR 36.20,95%CI 5.96-219.12)。
  • 透明隔腔穿孔信息可用于对考虑胎儿手术的家庭进行咨询并设定对出生后结局的合理预期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: In-utero repair of an open neural tube defect (ONTD) reduces the risk of developing severe hydrocephalus postnatally. Perforation of the cavum septi pellucidi (CSP) may reflect increased intraventricular pressure in the fetal brain. We sought to evaluate the association of perforated CSP visualized on fetal imaging before and/or after in-utero ONTD repair with the eventual need for hydrocephalus treatment by 1 year of age.

METHODS: This was a retrospective cohort study of consecutive patients who underwent laparotomy-assisted fetoscopic ONTD repair between 2014 and 2021 at a single center. Eligibility criteria for surgery were based on those of the Management of Myelomeningocele Study (MOMS), although a maternal prepregnancy body mass index of up to 40 kg/m2 was allowed. Fetal brain imaging was performed with ultrasound and magnetic resonance imaging (MRI) at referral and 6 weeks postoperatively. Stored ultrasound and MRI scans were reviewed retrospectively to assess CSP integrity. Medical records were reviewed to determine whether hydrocephalus treatment was needed within 1 year of age. Parametric and non-parametric tests were used as appropriate to compare outcomes between cases with perforated CSP and those with intact CSP as determined on ultrasound at referral. Logistic regression analysis was performed to assess the predictive performance of various imaging markers for the need for hydrocephalus treatment.

RESULTS: A total of 110 patients were included. Perforated CSP was identified in 20.6% and 22.6% of cases on preoperative ultrasound and MRI, respectively, and in 26.6% and 24.2% on postoperative ultrasound and MRI, respectively. Ventricular size increased between referral and after surgery (median, 11.00 (range, 5.89-21.45) mm vs 16.00 (range, 7.00-43.5) mm; P < 0.01), as did the proportion of cases with severe ventriculomegaly (ventricular width ≥ 15 mm) (12.7% vs 57.8%; P < 0.01). Complete CSP evaluation was achieved on preoperative ultrasound in 107 cases, of which 22 had a perforated CSP and 85 had an intact CSP. The perforated-CSP group presented with larger ventricles (mean, 14.32 ± 3.45 mm vs 10.37 ± 2.37 mm; P < 0.01) and a higher rate of severe ventriculomegaly (40.9% vs 5.9%; P < 0.01) compared to those with an intact CSP. The same trends were observed at 6 weeks postoperatively for mean ventricular size (median, 21.0 (range, 13.0-43.5) mm vs 14.3 (range, 7.0-29.0) mm; P < 0.01) and severe ventriculomegaly (95.0% vs 46.8%; P < 0.01). Cases with a perforated CSP at referral had a lower rate of hindbrain herniation (HBH) reversal postoperatively (65.0% vs 88.6%; P = 0.01) and were more likely to require treatment for hydrocephalus (89.5% vs 22.7%; P < 0.01). The strongest predictor of the need for hydrocephalus treatment within 1 year of age was lack of HBH reversal on MRI (odds ratio (OR), 36.20 (95% CI, 5.96-219.12); P < 0.01) followed by perforated CSP on ultrasound at referral (OR, 23.40 (95% CI, 5.42-100.98); P < 0.01) and by perforated CSP at 6-week postoperative ultrasound (OR, 19.48 (95% CI, 5.68-66.68); P < 0.01).

CONCLUSIONS: The detection of a perforated CSP in fetuses with ONTD can reliably identify those cases at highest risk for needing hydrocephalus treatment by 1 year of age. Evaluation of this brain structure can improve counseling of families considering fetal surgery for ONTD, in order to set appropriate expectations about postnatal outcome. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sanz Cortes M, Johnson RM, Sangi-Haghpeykar H, et al. Perforation of cavum septi pellucidi in open spina bifida and need for hydrocephalus treatment by 1 year of age. Ultrasound Obstet Gynecol. 2024. PMID: 37698345. doi:10.1002/uog.27480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。